Related Experiment Video
Updated: Feb 8, 2026

Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
SGLT2 inhibitors and the kidney: Effects and mechanisms
V Tsimihodimos1, T D Filippatos2, M S Elisaf1
1Department of Internal Medicine, School of Medicine, University of Ioannina, Ioannina, Greece.
Aims:
Numerous clinical trials have shown that sodium glucose cotransporter 2 (SGLT2) inhibitors exert a favorable effect on the indices of renal function (albuminuria, glomerular filtration rate decline over time) and the incidence of hard renal endpoints such as renal death or time to initiation of renal replacement therapy.
Materials And Methods:
In this review, we describe in detail the evidence regarding the nephroprotective mechanisms of SGLT2 inhibitors and describe the risk factors that may predispose to the development of acute kidney injury in patients receiving these drugs.
Results:
Although the impact of these drugs on renal hemodynamics seems to represent the most important renoprotective mechanism of action, many other effects of these compounds, including beneficial effects on metabolism and blood pressure, have been proposed to contribute to the observed clinical benefit.
Conclusions:
SGLT2 inhibitors clearly act beneficially in terms of kidney function with many proposed mechanisms.
More Related Videos
13:28Simple and Effective Administration and Visualization of Microparticles in the Circulatory System of Small Fishes Using Kidney Injection
Published on: June 17, 2018
09:17Characterization of the Effects of Migrastatic Inhibitors on 3D Tumor Spheroid Invasion by High-resolution Confocal Microscopy
Published on: September 16, 2019
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Kidney Structure
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Framing Effects
Reaction Mechanisms
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
Dipeptidyl Peptidase 4 Inhibitors